Pan-caspase inhibition reduces tubular apoptosis and proliferation and slows progression of disease in a rat model of polycystic kidney disease (PKD). It is unknown, however, which specific caspases are involved in PKD progression. Because caspase-3 is a major mediator of apoptosis, its role in autosomal recessive PKD was determined. Mice with caspase-3 gene deletion were crossed with mice harb...

The mTOR pathway plays an important role in a number of common renal diseases, including acute kidney injury (AKI), diabetic nephropathy (DN), and polycystic kidney diseases (PKD). The activity of mTOR complex 1 (mTORC1) is necessary for renal regeneration and repair after AKI, and inhibition of mTORC1 by rapamycin has been shown to delay recovery from ischemic AKI in animal studies, and to pro...

Many inherited diseases and non-hereditary disorders are common in the development of renal cystic diseases. Polycystic kidney disease (PKD) is a disorder developed within the kidneys in which grouping of cysts filled with water like fluid. PKD is responsible for 5-10% of end-stage renal failure treated by dialysis or transplantation. New experimental models, application of molecular biology te...

 ABSTRACT Background: Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disorder with genetic heterogeneity. Up to three loci are involved in this disease, PKDI on chromosome 16p13.3, PKD2 on 4q21, and a third locus of unknown location. Methods: Here we report the first molecular genetic study of ADPKD and the existence oflocus heterogeneity for ADPKD in the Iranian populatio...

Polycystic kidney disease (PKD) is a common genetic disorder leading to cyst formation in the kidneys and other organs that ultimately results in kidney failure and death. Currently, there is no therapy for slowing down or stopping the progression of PKD. In this study, we identified the disintegrin metalloenzyme 17 (ADAM17) as a key regulator of cell proliferation in kidney tissues of conditio...

Polycystic kidney disease (PKD) is one of the most common genetic diseases in humans. We contend that it may be an emerging infectious disease and/or microbial toxicosis in a vulnerable human subpopulation. Use of a differential activation protocol for the Limulus amebocyte lysate (LAL) assay showed bacterial endotoxin and fungal (1-->3)-beta-D-glucans in cyst fluids from human kidneys with PKD...

Polycystic kidneys diseases (PKD) are a group of monogenic kidney disorders that lead to cyst development in the kidneys. Polycystic kidney diseases are a common indication for renal transplantation and dialysis and a leading cause of end-stage renal disease (ESRD). There are two types of PKD, the autosomal dominant type called ADPKD with an estimated prevalence rate of 1:400-1:1000 worldwide (...

Submit Manuscript | http://medcraveonline.com Abbreviations: CKD: Chronic Kidney Disease; AKI: Acute Kidney Injury; PE: Pre-Eclampsia; SLE: Systemic Lupus Erythematosus; RA: Rheumatoid Arthritis; SS: Systemic Scleroderma; ESRD: End-Stage Renal Disease; CVDs: Cardiovascular Diseases; GFR: Glomerular Filtration Rate; sCR: Serum Creatinine; LLAC: Lupuslike anticoagulant; PE-AKI: Preeclampsia Acute...

Submit Manuscript | http://medcraveonline.com Abbreviations: CKD: Chronic Kidney Disease; AKI: Acute Kidney Injury; PE: Pre-Eclampsia; SLE: Systemic Lupus Erythematosus; RA: Rheumatoid Arthritis; SS: Systemic Scleroderma; ESRD: End-Stage Renal Disease; CVDs: Cardiovascular Diseases; GFR: Glomerular Filtration Rate; sCR: Serum Creatinine; LLAC: Lupuslike anticoagulant; PE-AKI: Preeclampsia Acute...

Autosomal dominant polycystic kidney disease (ADPKD), the most common form of polycystic kidney disease (PKD), is a disorder with characteristics of neoplasia. However, it is not known whether renal transplant recipients with PKD have an increased risk of cancer. Data from the Scientific Registry of Transplant Recipients, which contains information on all solid organ transplant recipients in th...